Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer.
Mark P. Saunders
No relevant relationships to disclose
Istvan Lang
No relevant relationships to disclose
Eugenio Marcuello
No relevant relationships to disclose
Vito Lorusso
No relevant relationships to disclose
Janja Ocvirk
Honoraria - Merck; Roche
Dongbok Shin
No relevant relationships to disclose
Derek J. Jonker
No relevant relationships to disclose
Stuart Osborne
Employment or Leadership Position - Roche
Markus Loeffler
Employment or Leadership Position - Roche
Daniel Waterkamp
Employment or Leadership Position - Roche
David Cunningham
Research Funding - Amgen; AstraZeneca; Celgene; Merck KGaA; Novartis; Roche